R3CE is a clinically validated 3D single-cell culture platform and can seize the golden window of cancer treatment for patients!

Since cancer cells proliferate and mutate quickly, patients typically have to test a variety of medication to find an effective treatment. Each round of testing typically takes three to six months. However, with R³CE serving as a single-cell proliferation platform, patients’ cancer cells can be cultured in-vitro. This will allow doctors to find effective remedies for patients.

 Advantages of R³CE Technology Platform:

• Functional on different plate types
• Ease of observation due to transparent substrate
• Enables analysis and culturing of various biological cells.
• Spheroids cultured are highly uniform and 400 times the size of the original sample cells after 7 days of proliferation.
• Clinically validated single cell amplification platform.
• Similar protocol to 2D cultures
• Cultures are easy to maintain and can be sampled through treatment-free processes.
• Spheroids are oftentimes a more accurate representation of the human body’s reactions and conditions.
• Accurately predicts drug candidates and provides result in three weeks. These results were obtained through double-blind experiments with prestigious international clinical centers.
• Animal 3D tumor cells cultured by R³CE proliferate faster than 2D cultures and can be used in experiments.

 Look for: 

Hospitals, research labs, medical centers, technical cooperation, precision medicine and tumor related research and testing

InnoZone  Booth No. A051